Gen-Probe announced yesterday that it has begun a clinical trial designed to seek U.S. regulatory approval of the PROGENSA® PCA3 assay.
Filed under: Diagnosis, Risk | Tagged: clinical trial, PCA3, Progensa | 5 Comments »
Cougar Biotech and FDA agree on new abiraterone trial
Posted on February 10, 2009 by Sitemaster
According to MarketWatch, Cougar Biotechnology has announced agreement with the US Food & Drug Administration regarding the structure of another Phase III trial of abiraterone acetate in prostate cancer.
Filed under: Drugs in development, Management, Treatment | Tagged: abiraterone, clinical trial | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site
